Many US patients opt for obesity drug injections, defying some expectations

Pharmaceutical industry experts initially expected US patients to prefer obesity drug pills due to convenience. However, current data reveals a different trend, as eight out of ten doctors report that many patients are instead opting for injectables. This preference for obesity drug injections defies the original expectations of industry specialists regarding patient behavior and medication delivery preferences, showing that the demand for injectable treatments remains strong despite the perceived convenience of oral pill alternatives.